Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb bioresorbable scaffold implantation: results from the GABI-R registry
Event:
ESC Congress 2019
Topic:
Stents
Session:
Percutaneous coronary syndrome: pharma and devices